If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Interim Management Statement

18 Jul 2013 07:00

RNS Number : 5720J
Biome Technologies PLC
18 July 2013
Β 

ο»Ώ

18 July 2013

Β 

Biome Technologies plc ("Biome", "the Company" or "the Group")

Interim Trading Statement

Β 

Β 

Biome Technologies plc, a leading bioplastics and RF technology business, today publishes a trading update, ahead of its interim results for the six-month period ended 30 June 2013, which are expected to be announced on 2 September 2013.

Β 

Trading Update

Β 

Total Group revenues achieved for the second quarter were Β£0.5m (Q1 2013: Β£0.4m). As previously noted, this year is anticipated to be second half weighted and the Board expects revenue growth in both divisions as the year progresses.

Β 

On 23 May 2013 the Board, having completed a settlement with regard to two legacy long leases on buildings in Southampton for a cash sum of Β£895,000, plus VAT, proposed a process of capital reduction, consolidation and sub-division of existing ordinary shares. This process was approved by Shareholders on 20 June and the consolidated shares admitted to AIM on 16 July 2013.

Β 

The Board is pleased to confirm that the Court approved the proposed capital reduction on 17 July 2013. This decision will allow us to complete the process, which the Board believes will provide a clearer view of the Company's financial position and rationalise the unusually large shareholder base of the Company.

Β 

The Group's cash position at 30 June 2013 was Β£3.9m (31 March 2013: Β£5.8m).

Β 

We continue to make progress with the strategy to commercialise and develop wholly owned intellectual property and our performance remains in line with the Board's expectations.

Β 

Bioplastics Division

Β 

The Q2 2013 revenues for the Bioplastics Division were Β£0.1m (Q1 2013: Β£0.2m). This division is focused on developing high margin, application led products with enhanced level of functionality. Two key projects are currently being undertaken for single use foodservice products and single use coffee capsules.

Β 

The first of these projects remains in the development phase with biodegradation certification now completed and composting trials underway. This project is expected to remain under development until the final quarter of 2013.

Β 

The second project required significant technical support in the second quarter to ensure optimisation of our customer's manufacturing performance in the USA. This project is now passing into the manufacturing phase and shipments of substantially increased tonnages for the second half are in prospect.

Β 

In the first quarter, the division was awarded a grant by the Government-backed Technology Strategy Board (TSB). Work on this project started in the second quarter in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining and the Group has subsequently applied for a further grant to broaden this work. The result of this application is expected in the near future.

Β 

Stanelco RF Technologies Division

Β 

The Q2 revenues for the RF Division were Β£0.4m (Q1 2013: Β£0.2m). As previously reported, a number of optical fibre furnace deliveries were delayed at the end of 2012 due to some uncertainties in the Chinese fibre market. Some pick-up was evident in the second quarter and Stanelco RF has tendered for a number of significant projects for the second half but the market is yet to return to the levels seen previously.

Β 

Progress continues on the Durapipe project with results from time-based testing of the final pipe-work made with the Stanelco prototypes awaited. Transition to commercial production on this project is expected in the second half. Enquiry and order levels for general industrial equipment are robust and the partnership with Forsstrom continues to build.

Β 

-Ends-

Β 

For further information please contact:

Β 

Biome Technologies plc

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

Β 

Β 

David Hart/James Thomas

Β 

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

Β 

Β 

First Columbus

Β 

Chris Crawford/Kelly Gardiner

Β 

www.first-columbus.com

Tel: +44 (0) 20 3002 2070

Β 

Β 

FTI Consulting

Β 

Oliver Winters/Latika Shah

Tel: +44 (0) 20 7831 3113

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBLGDRXDBBGXR
Date   Source Headline
3rd Sep 20127:00 amRNSInterim Results
29th Aug 20127:00 amRNSPrototype Delivery for Stanelco RF Technologies
19th Jul 20127:00 amRNSInterim Trading Statement
17th Jul 20127:00 amRNSFinancing and Loan Repayment
12th Jul 20127:00 amRNSPatent Litigation Update
10th Jul 20124:40 pmRNSSecond Price Monitoring Extn
10th Jul 20124:35 pmRNSPrice Monitoring Extension
19th Jun 20127:00 amRNSLoan Facility Extension/Directorate Change
31st May 20127:00 amRNSTrading Update
15th May 20124:40 pmRNSSecond Price Monitoring Extn
15th May 20124:35 pmRNSPrice Monitoring Extension
25th Apr 20121:35 pmRNSResult of AGM
25th Apr 20127:00 amRNSTrading Update
4th Apr 20127:00 amRNSNotification of Award under the Public Equity Plan
29th Mar 20127:00 amRNSPreliminary Results
19th Jan 20127:00 amRNSPre-close Trading Statement
10th Jan 20127:00 amRNSContract for RF Technologies Business
16th Dec 20111:27 pmRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSLoan Reclassification
4th Nov 20117:00 amRNSTrading Update
21st Oct 20114:35 pmRNSPrice Monitoring Extension
19th Sep 20117:00 amRNSSector Reclassification
1st Sep 20117:01 amRNSDirectorate Changes
1st Sep 20117:00 amRNSInterim Results
16th May 201111:07 amRNSDirector/PDMR Shareholding
9th May 20117:00 amRNSDirector/PDMR Shareholding
5th May 20112:28 pmRNSResult of AGM
5th May 20117:00 amRNSTrading Update
12th Apr 201112:22 pmRNSHolding(s) in Company
28th Mar 20114:23 pmRNSAnnual Report &Accounts for 2010 and Notice of AGM
24th Mar 20117:00 amRNSPreliminary Results
28th Feb 201112:22 pmRNSTotal Voting Rights
23rd Feb 20114:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20114:35 pmRNSPrice Monitoring Extension
17th Feb 20117:00 amRNSAppointment of Nominated Adviser & Joint Brokers
5th Nov 20107:00 amRNSTrading Update
14th Oct 20107:00 amRNSDirector/PDMR Shareholding
7th Oct 20107:00 amRNSDirectorate Change
5th Oct 20107:00 amRNSNotification of Awards under Public Equity Plan
17th Sep 20104:37 pmRNSPrice Monitoring Extension
27th Aug 20107:00 amRNSHalf Yearly Report
13th Jul 20107:55 amRNSFirst Day of Dealings on AIM
12th Jul 20107:00 amRNSChange of Name
1st Jul 201010:07 amRNSTotal Voting Rights
22nd Jun 20101:07 pmRNSResult of AGM
22nd Jun 20107:00 amRNSAnnual General Meeting & Trading Update
21st Jun 20104:41 pmRNSSch 1 update - Stanelco plc
21st Jun 20104:15 pmRNSDirector/PDMR Shareholding: Correction
15th Jun 20105:03 pmRNSDirector/PDMR Shareholding
14th Jun 201012:40 pmRNSSchedule 1 - Stanelco PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.